Arcturis Data

What Arcturis Data does

Arcturis Data is a UK-based real-world data (RWD) company that curates enriched, regulatory-grade health datasets from NHS hospital partners to support pharmaceutical and biotechnology drug development. The company operates a Real-World Data Network (RWD Network) consisting of strategic research agreements with major NHS trusts — including Oxford University Hospitals, Guy's and St Thomas', NHS Greater Glasgow and Clyde, University College London Hospitals, Leeds Teaching Hospitals, and Royal Berkshire NHS Foundation Trust — providing access to longitudinal secondary-care patient records. The network received research database ethical approval from the NHS Health Research Authority (REC ref: 24/YH/0164) with CAG support (24/CAG/0096), enabling legally compliant access to anonymised clinical data across all therapeutic areas including oncology, cardiovascular, respiratory, metabolic and rare diseases.

Arcturis's platform rests on three proprietary technology layers: ArcTEX, a transformer-based Natural Language Processing (NLP) framework that extracts biomarker and disease-specific data from unstructured clinical reports with 98.3% average accuracy and provides confidence scores to avoid hallucinations; ArcMAP, a machine learning-assisted concept mapping tool that standardises medical concepts to SNOMED CT, DM+D, LOINC and OMOP with 98.20% exact match on medication names; and a Next Generation Sequencing platform that integrates genomics, transcriptomics, proteomics and single-cell multiome data with electronic health records. The company also deploys AI models for predictive analytics (e.g., chronic kidney disease prognosis forecasting with ROC AUC of 70–88%) and anomaly detection across its data pipeline.

The business model is built on bespoke enterprise research contracts with top-tier global pharmaceutical companies, specialist pharma and biotech firms, and AI/in silico drug discovery companies. Revenue is generated through professional services for real-world evidence generation (external control arms, regulatory submissions, health technology appraisals, post-authorisation safety studies) supplemented by recurring data access arrangements via multi-year Strategic Research Agreements with NHS partners. GTM is direct enterprise sales with a dedicated commercial team including a Chief Commercial Officer and Lead Business Development Manager.

Name

Arcturis Data

Legal name

Arcturis Data Limited

Website

https://arcturisdata.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Arcturis Data curates regulatory-grade, enriched real-world health data from a network of NHS hospital trusts and provides AI-powered analytics and real-world evidence services to pharmaceutical, biotechnology, and AI-driven drug discovery companies.

Ownership category

akta.pro rank

Product category

Real-World Health Data Analytics

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)

akta.pro secondary industries

Real-World Data (RWD) Platforms & Clinical Data Curation (HLACAIAJ), Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF), Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK), Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)

Keywords

• Real-world health data
• Real-world evidence analytics
• Clinical data platform
• Biomarker extraction NLP
• Multi-omics data services

Headquarters

HQ city

Oxford

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Real-World Evidence Research Services: Arcturis provides research services to pharmaceutical and biotechnology companies using curated real-world health data. The company tailors highly curated and enriched data to individual client needs to generate bespoke insights advancing their research programmes. Revenue is generated through research contracts with life sciences clients for activities across drug discovery, clinical development, regulatory submissions, and post-approval studies.
2. Data Access and Licensing: Arcturis operates through Strategic Research Agreements with NHS partners, investing in NHS hospital partners to support curation of high-quality, research-ready health data. The company generates revenue from research undertaken for clients, with NHS partners receiving grant funding and revenue share.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Arcturis Data curates and licenses an HRA-approved Real-World Data (RWD) Network of longitudinal UK NHS secondary-care patient records enriched with unstructured, molecular, and genetic data, and delivers bespoke real-world evidence (RWE) research services to pharmaceutical, biotechnology and AI drug discovery clients. The offering is enabled by proprietary AI tools ArcTEX (NLP for biomarker extraction) and ArcMAP (ML-assisted concept mapping) operating on a Common Data Model.

Product overview

Arcturis Data is a real-world data company offering a unified platform and suite of tools for regulatory-grade health data analytics. The core offering is the Arcturis Real-World Data Network (RWD Network), an HRA-approved research database providing access to enriched UK NHS health data. This platform is enhanced by two proprietary AI-powered tools: ArcTEX (Natural Language Processing for extracting biomarkers from unstructured clinical reports) and ArcMAP (Machine Learning-assisted concept mapping to standardise medical terminologies). The Next Generation Sequencing Platform links genetic and multi-omics data to electronic health records. Together with RWE Analytics services, these products enable pharmaceutical and biotech companies to generate real-world evidence for clinical trials, regulatory submissions, health technology appraisals, and post-authorisation safety studies.

Differentiator

Problem solved

Functional benefit

Products and services

• Arcturis Real-World Data Network (RWD Network) HRA-approved research database providing access to diverse and enriched real-world health data through partnerships with NHS hospitals. Curates disease-specific collections of anonymised clinical data including structured data, unstructured data, and multi-modal molecular data for regulatory-grade real-world evidence generation.
• ArcTEX (Arcturis Text Enrichment and Extraction) Proprietary Natural Language Processing framework for extracting biomarker and disease-specific data from unstructured clinical reports including pathology reports, clinical letters, and free-text documents. Provides confidence scores per extraction and achieves 98.3% average accuracy.
• ArcMAP (ML-Assisted Concept Mapping) Machine learning-based tool for mapping medical concepts to standard terminologies including SNOMED CT, LOINC, DM+D, and OMOP. Enables automated standardisation of medication names (98.20% exact match) and laboratory test names from diverse NHS hospital data sources.
• Next Generation Sequencing Platform Platform enabling curation of deep, disease-specific clinical data linked with genetic and molecular data including genomics (DNA), transcriptomic (RNA), and proteomic data. Supports whole genome sequencing, single-cell analysis, and multi-omics integration for precision medicine research.
• Precision Real-World Health Data Access to precision, enriched, regulatory-grade UK health data through the RWD Network, including enhanced electronic health records, unstructured data, population data, and molecular multi-modal data, providing longitudinal health records for end-to-end patient journey views.
• External Control Arm Services Generation of external control arms from real-world data for clinical trial comparison. Uses target trial emulation framework to match patients to inclusion/exclusion criteria and replicate trial endpoints using longitudinal real-world data.
• Real-World Evidence (RWE) Analytics Regulatory-grade real-world evidence insights generation service supporting pharmaceutical and biotechnology companies, including patient characterisation, treatment efficacy analysis, clinical outcomes research, external control arms, natural history studies, and post-authorisation safety studies.

Quantifiable outcome

• 98.3% average accuracy in biomarker extraction from unstructured clinical reports
• +1 more outcomes

Named customers3 records

Segments1 record

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature4 records

Partnerships

Eight partnerships are on record, tiered core.

• Royal Berkshire NHS Foundation TrustcoreStrategic or Co-development Partner · 1 November 2025Multi-year strategic partnership to develop real-world data for drug development and innovative medicine adoption. The partnership leverages Royal Berkshire's clinical expertise and Arcturis's data capabilities, with a focus on oncology through the Berkshire Cancer Centre. Includes initiation of a two-year Arcturis-sponsored fellowship programme within the trust's Health Data Institute.
• Leeds Teaching Hospitals NHS TrustcoreStrategic or Co-development Partner · 12 June 2025Multi-year strategic partnership making Leeds Teaching Hospitals part of Arcturis's RWD Network. Leeds is one of the largest acute hospital trusts in Europe, providing treatment to around 1.6 million patients through seven regional hospitals. Partnership brings clinical expertise in cardiology, neurology and oncology.
• University College London Hospitals NHS Foundation TrustcoreStrategic or Co-development Partner · 14 May 2025Long-term strategic partnership continuing expansion of the RWD Network. UCLH provides treatment to over one million patients per year across six hospital sites serving 1.3 million people. Partnership focuses on oncology, neurology, cardiology and metabolic disease.
• DATA-CAN (UK Health Data Research Hub for Cancer)coreStrategic or Co-development Partner · 19 February 2025Partnership combines Arcturis's expertise in real-world data with DATA-CAN's unique oncology-focussed health data curation network. Partnership increases availability and quality of cancer datasets through curation combining electronic patient records with unstructured data. Datasets stored within NHS Research Secure Data Environment Network.
• NHS Greater Glasgow and ClydecoreStrategic or Co-development Partner · 3 December 2024Multi-year strategic research agreement with the largest health board in Scotland (23 hospitals). Provides access to anonymised health data through the West of Scotland Safe Haven. Enables curation of deep, enriched real-world health datasets across all therapy areas including oncology, respiratory and metabolic diseases.
• Guy's and St Thomas' NHS Foundation TrustcoreStrategic or Co-development Partner · 1 October 2024Multi-year Strategic Research Agreement allowing anonymised NHS data from an established Research Ethics approved database to be made available for research supporting development of novel cancer therapies. Initial focus in oncology covering gynaecological, lung, prostate and bladder cancers. Trust provides 2.8 million patient contacts annually.
• Oxford University Hospitals NHS Foundation TrustcoreStrategic or Co-development Partner · 3 May 2024Programme to develop deep oncology real-world datasets building on longstanding multi-disease strategic research partnership. OUH provides access to deep longitudinal anonymised oncology data within the Thames Valley and Surrey Secure Data Environment. Focus on integrating molecular and clinical data with biomarkers from unstructured sources.
• Health Data Research UK (HDR UK)coreStrategic or Co-development PartnerPartnership through DATA-CAN, which works in partnership with HDR UK. HDR UK is the UK's national institute for health data science, whose mission is to accelerate trustworthy use of health data to enable discoveries that improve people's lives.

Scale indicators4 records

Expansion highlights6 records

Emerging players

• Owkin: AI-driven federated learning and multimodal biomedical data company serving pharma R&D. Comparable multi-modal (imaging, genomics, EHR) approach and pharma enterprise customers; operates a federated network model conceptually similar to Arcturis's Secure Data Environment approach.

Direct peers

• ConcertAI: AI-driven real-world evidence and clinical research company focused on oncology and specialty therapeutics. Comparable as a curated RWD/RWE provider for pharma with regulatory-grade datasets and external control arm services.
• Datavant: Health data connectivity company enabling privacy-preserving linking of real-world data sources for research. Comparable in enabling cross-institution data curation for pharma R&D and RWE generation.
• TriNetX: Global health research network offering real-world data access for clinical trial design, feasibility, and RWE. Directly comparable federated network model leveraging hospital EHR data and pharma enterprise customers.
• Flatiron Health: US-based oncology-focused real-world data and RWE platform acquired by Roche for $1.9B. Directly comparable as a curated EHR-derived RWD/RWE provider serving top-tier pharma, with analogous technology stack for unstructured-data extraction and regulatory-grade datasets.
• Tempus Labs: Publicly listed AI-powered precision medicine company combining multi-modal molecular data (genomics, transcriptomics, imaging) with EHR for pharma R&D and clinical decision support. Comparable multi-omics + EHR integration model and enterprise pharma customer base.
• Cota Healthcare: Oncology-focused real-world data company providing curated EHR-derived datasets to pharma for RWE generation. Directly comparable in regulatory-grade data curation, oncology focus, and pharma enterprise customers.

Broad incumbents

• IQVIA: World's largest CRO and RWE provider with global longitudinal prescription, claims and EHR datasets. Overlaps with Arcturis on RWE analytics and external control arms but operates at vastly greater scale across geographies and therapeutic areas.
• Optum (UnitedHealth Group): Largest US health data and analytics business combining claims, EHR and clinical data for pharma RWE. Comparable regulatory-grade data asset and pharma customer base, but at hyperscale and primarily US-centric.
• Health Catalyst: Healthcare data and analytics platform provider combining clinical, claims and operational data for providers and life sciences. Comparable data warehousing / curation capability and pharma RWE offering, though broader in scope than Arcturis's curated secondary-care focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/arcturis-data

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arcturis Data